Next Article in Journal
The RNA Capping Enzyme Domain in Protein A is Essential for Flock House Virus Replication
Previous Article in Journal
Capsid Structure of dsRNA Fungal Viruses
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Viruses
Volume 10
Issue 9
10.3390/v10090482
viruses-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Characterization of vB_Kpn_F48, a Newly Discovered Lytic Bacteriophage for Klebsiella pneumoniae of Sequence Type 101

by
Nagaia Ciacci
1,2,
Marco Maria D’Andrea
1,2,
Pasquale Marmo
1,
Elisa Demattè
3,
Francesco Amisano
4,
Vincenzo Di Pilato
5,
Maurizio Fraziano
1,
Pietro Lupetti
6,
Gian Maria Rossolini
5,7 and
Maria Cristina Thaller
1,*
1
Department of Biology, University of Rome “Tor Vergata”, 00133 Rome, Italy
2
Department of Medical Biotechnologies, University of Siena, 53100 Siena, Italy
3
Center for Integrative Biology, CIBIO, University of Trento, 38122 Trento, Italy
4
InBioS—Center for Protein Engineering, Department of Life Sciences, University of Liège, Sart-Tilman, 4000 Liège, Belgium
5
Department of Experimental and Clinical Medicine, University of Florence, 50134 Florence, Italy
6
Department of Life Sciences, University of Siena, 53100 Siena, Italy
7
Clinical Microbiology and Virology Unit, Florence Careggi University Hospital, 50134 Florence, Italy
*
Author to whom correspondence should be addressed.
Viruses 2018, 10(9), 482; https://doi.org/10.3390/v10090482
Submission received: 22 August 2018 / Revised: 5 September 2018 / Accepted: 7 September 2018 / Published: 9 September 2018
(This article belongs to the Section Bacterial Viruses)
Browse Figures
Versions Notes

Abstract

:
Resistance to carbapenems in Enterobacteriaceae, including Klebsiella pneumoniae, represents a major clinical problem given the lack of effective alternative antibiotics. Bacteriophages could provide a valuable tool to control the dissemination of antibiotic resistant isolates, for the decolonization of colonized individuals and for treatment purposes. In this work, we have characterized a lytic bacteriophage, named vB_Kpn_F48, specific for K. pneumoniae isolates belonging to clonal group 101. Phage vB_Kpn_F48 was classified as a member of Myoviridae, order Caudovirales, on the basis of transmission electron microscopy analysis. Physiological characterization demonstrated that vB_Kpn_F48 showed a narrow host range, a short latent period, a low burst size and it is highly stable to both temperature and pH variations. High throughput sequencing and bioinformatics analysis revealed that the phage is characterized by a 171 Kb dsDNA genome that lacks genes undesirable for a therapeutic perspective such integrases, antibiotic resistance genes and toxin encoding genes. Phylogenetic analysis suggests that vB_Kpn_F48 is a T4-like bacteriophage which belongs to a novel genus within the Tevenvirinae subfamily, which we tentatively named “F48virus”. Considering the narrow host range, the genomic features and overall physiological parameters phage vB_Kpn_F48 could be a promising candidate to be used alone or in cocktails for phage therapy applications.

1. Introduction

The extensive usage of antibiotics has led to the emergence and dissemination of antibiotic resistant bacteria, with an increasing number of reports in hospital settings of strains showing multidrug resistant (MDR), extremely drug resistant (XDR), or even pandrug resistant (PDR) phenotypes [1]. This situation is further complicated by the slow rate of discovery and development of new antibiotics, with the net result of a progressive reduction of effective therapeutic options for the management of serious infections [2,3]. Consequently, antibiotic resistance has become one of the major public health problems [3,4].
Klebsiella pneumoniae has emerged as one of the most challenging antibiotic-resistant pathogens, since it can cause a variety of infections (e.g., urinary tract infections, pneumonia, intra-abdominal infections, surgical site infections, bacteremia) and exhibits a remarkable propensity to acquire MDR and XDR phenotypes. Indeed, some clonal lineages of K. pneumoniae have acquired resistance determinants to most antibiotics available for treating these infections, including fluoroquinolones, aminoglycosides, expanded-spectrum cephalosporins and carbapenems, while retaining a notable propensity to disseminate in healthcare settings. Typical representatives of these “high-risk clones” (HiRiCs) include the Clonal Group (CG) 258 strains, which have played a major role in the dissemination of KPC-type carbapenemases, the CG15 strains, which are the second most prevalent CG responsible for ≈20% of all outbreaks, and the CG17, CG37, CG101 and CG147 strains [5].
In particular members of CG101, represented by strains of Sequence Type (ST) 101 and related variants (e.g., ST1789 and ST1633), are wide-spreading in several European and North African countries [6,7,8,9,10,11,12,13,14,15,16,17], and differently from other STs, exhibit a notable promiscuity in term of associated clinically-relevant resistance determinants, such as carbapenemases of the KPC, OXA-48, VIM and NDM types [6,11,18,19].
Among potential alternatives to conventional antibiotics against resistant pathogens, bacteriophages are being reconsidered with interest as valuable tools, given their ability to rapidly and selectively kill specific bacterial clones [20,21].
Here we describe the isolation and characterization of a novel bacteriophage of the Myoviridae family with a lytic activity specific to K. pneumoniae strains belonging to ST101 and other members of CG101.

2. Materials and Methods

2.1. Bacterial Host and Culture Conditions

The K. pneumoniae clinical strain 12C47, isolated in 2011 in Italy, was used as host for the isolation and propagation of the vB_Kpn_F48 bacteriophage. The strain was part of the collection characterized during the first national survey on carbapenem-resistant Enterobacteriaceae carried out in Italy in 2011, produced the KPC-2 carbapenemase, displayed a MDR phenotype, and was typed as ST101 by multi-locus sequence typing (MLST) [22].

2.2. Phage Isolation and Purification

Bacteriophage vB_Kpn_F48 was isolated from sewage wastewaters collected at the Florence Careggi University hospital by using the double-layer overlay technique and K. pneumoniae 12C47 as the indicator strain, as previously described [23]. Pure bacteriophage suspensions were obtained by three rounds of single plaque purification and re-infection of exponentially growing 12C47, as reported elsewhere [24]. Phage titer, expressed in plaque forming units (PFU)/mL, was estimated by the soft-agar overlay method [23].

2.3. Transmission Electron Microscopy (TEM)

Aliquots of bacteriophages particles preparations were centrifuged at 25,000× g for 1 h and suspended at ~1012 PFU/mL in SM buffer (10 mM Tris–HCl, pH 7.5; 100 mM NaCl; 10 mM MgSO4). Samples were processed by negative stain with 2% uranyl acetate and examined by a FEI Tecnai 12 (FEI, Eindhoven, The Netherlands) transmission electron microscope (TEM) fitted with an Osis Morada 2 × 4K CCD camera (Olympus, Shinjuku, Tokyo, Japan).

2.4. Determination of Bacteriophage Host Range

Host range of phage vB_Kpn_F48 was determined by the spot test technique using 61 previously characterized K. pneumoniae strains (Table 1), 24 enterobacterial isolates (Klebsiella variicola, n = 4; Klebsiella quasipneumoniae subsp. quasipneumoniae, n = 2; Klebsiella oxytoca, n = 1; Enterobacter ludwigii, n = 1; Enterobacter gergoviae, n = 1; Enterobacter sakazakii, n = 1; Serratia marcescens, n = 3; Citrobacter freundii, n = 1; Providencia stuartii, n = 1; Edwardsiella tarda, n = 1 and Escherichia coli, n = 8), 18 gram negative non fermenters (Pseudomonas aeruginosa, n = 14; Acinetobacter baumannii, n = 4) and 16 E. coli isolates obtained from stools of healthy children, as described by Hsu [25]. All strains with the exception of commensal E. coli were of nosocomial origin, and K. pneumoniae strains were representatives of clinically relevant and globally diffused clones. Each strain was grown in 5 mL of LB at 37 °C with shaking to an OD600 of 0.5, then centrifuged at 4500× g for 10 min and suspended in 5 mL of SM buffer. A 0.1 mL volume of the bacterial suspension was mixed with 4.5 mL of molten soft-agar, poured onto an LB agar (LBA) plate and, after solidification of the agar, 0.01 mL of phage suspension (titer ~107 PFU/mL) were spotted on the overlay. Sensitivity to the vB_Kpn_F48 infection was tentatively assessed by the observation of a lysis halo at the spot after overnight (ON) incubation at 35 ± 2 °C, and then confirmed by the efficiency of plating (EOP) method as described below.

2.5. Preparation of High Titer Bacteriophage Suspensions

A large-scale preparation of vB_Kpn_F48 was obtained by the double-layer overlay technique. Briefly, an ON culture of strain 12C47 was centrifuged at 4500× g for 10 min and the bacterial pellet was suspended in 1/10 of the starting volume in SM buffer. A 0.1 mL aliquot of bacteriophage preparation with a titer of 1 × 106 PFU/mL, previously filtered through 0.22 μm filter, was added to 0.2 mL of the bacterial suspension. After incubation of 20 min at 37 °C, the mixture was added to 4.5 mL of molten soft-agar and plated onto an LBA plate. Following an ON incubation at 37 °C, phages were recovered by adding 5 mL of SM buffer to each plate and incubating for 2 h at room temperature (RT) with gentle shaking. The soft-agar layer and SM buffer were then scraped and centrifuged at 4500× g for 10 min. The supernatant was collected, filtered through a 0.22 μm filter and stored at 4 °C. For long-term storage, phage aliquots were maintained in SM buffer supplemented with 25% glycerol at −80 °C.

2.6. Efficiency of Plating (EOP)

All K. pneumoniae isolates sensitive to phage vB_Kpn_F48 in the spot test assay (n = 14) were selected for the determination of EOP as described by Khan Mirzaei and Nilsson [27]. The EOP was computed as the ratio between PFU/mL on a sensitive strain and PFU/mL on the indicator strain and then used to rank each strain as “high productive” (EOP ≥ 0.5), “medium productive” (0.1 ≤ EOP < 0.5), “low productive” (0.001 < EOP < 0.1) or “inefficient” (EOP ≤ 0001). The assay was performed in triplicate for each combination of bacterial strain/phage dilution and results are reported as the mean of three observations.

2.7. One-Step Growth Curve

The dynamic change in phage particles number during a replicative cycle was monitored to determine the latency period, the eclipse period and the burst size of vB_Kpn_F48 as previously described [28] with minor modifications. Briefly, the host strain 12C47 was grown in aerobic conditions at 37 °C to mid-exponential phase (OD600 = 0.3–0.4, corresponding to ≈1–2 × 108 CFU/mL). The culture was then centrifuged at 4000× g for 10 min at 4 °C, and suspended in a 1/10 volume of SM buffer; a 0.1 mL of bacteriophage was then added to 0.9 mL of the bacterial cell suspension to achieve a Multiplicity of Infection (MOI) of 0.01. Phages were allowed to absorb for 5 min at 37 °C in a water-bath, and then the mixture was centrifuged twice at 13,000× g for 2 min in order to eliminate the non-absorbed phages. The pellet was then suspended in 1 mL of SM buffer, diluted 1 × 10−3 in 10 mL of LB medium and incubated at 37 °C in a water-bath. Two aliquots were taken at 0, 5, 10, 20, 40, 50, 60, 70 and 80 min post-infection. One aliquot was diluted immediately and plated for phage titration, while the other was treated with 2% chloroform, shaken briefly, set aside for 10 min at RT and centrifuged. The aqueous phase of the latter aliquot was then titrated to determine intracellular phage concentrations. Results are reported as the average number of phages released per infected host cell, and the burst size was computed as the ratio of the final count of released phage particles to the initial count of infected bacterial cells during the latent period [29]. Experiments were performed in triplicate and results are reported as the mean of three observations ± SD.

2.8. Influence of Physical Agents on Phage Viability

Stability of vB_Kpn_F48 to different pH values was evaluated by suspending phages at approximately 107 PFU/mL in aliquots of 1 mL SM buffer, previously adjusted with 1 M NaOH or 1 M HCl, to yield a pH range from 2.0 to 11.0 with intervals of 1 unit. Phage preparations were incubated at RT for 60 min. Stability of vB_Kpn_F48 to different temperatures was determined by incubation of phage preparations (≈107 PFU/mL) at 25 °C (control), 40 °C, 50 °C, 60 °C, 65 °C and 70 °C for 10, 20, 40 and 60 min. In both cases, serial dilutions of each sample were tested against strain 12C47 in a double-layer agar assay to check for the lytic activity of the phage. Assays were performed in triplicate and the results are reported as the mean of phage counts (PFU/mL) ± SD.

2.9. Time-Kill Assay

To determine the activity of phage vB_Kpn_F48 against strain 12C47 in vitro, a time-kill assay was performed using a modified protocol [30]. The indicator strain was grown in 45 mL LB medium at 37 °C to OD600 = 0.2 (approximately 0.6 × 108 CFU/mL) and infected with 5 mL phage suspension at about 5 × 108 PFU/mL (MOI = 1), 5 × 107 PFU/mL (MOI = 0.1) or 5 × 106 PFU/mL (MOI = 0.01). A non-infected culture of 12C47 was set up as negative control. All samples were incubated at 37 °C with shaking, and 1 mL aliquots were collected at 30 min time intervals for 7 h and at 24 h post-infection. Each aliquot was centrifuged twice at 13,000× g for 2 min in order to eliminate the nonabsorbed phages and the pellet was then suspended in 1 mL of 0.9% NaCl. Each sample was finally serially diluted [31] and plated on LBA for enumeration of viable colonies following ON incubation at 35 ± 2 °C. Experiments were performed in triplicate and results are reported as the mean of three observations ± SD and expressed as log-transformed values (log CFU/mL) over time.

2.10. Rate of Appearance of Phage-Resistant Mutants

The rate of phage-resistant mutant emergence was determined by the method described by Merabishvili [32] by mixing 1 mL of exponentially growing (~108 CFU/mL) culture of 12C47 with phage lysate to reach a MOI of 100. After 10 min of incubation at 37 °C with shaking, four 10-fold serial dilutions (101–104) in SM were prepared and 0.1 mL of each dilution was spread on LBA plates. Colonies were enumerated after overnight incubation at 35 °C. A non-infected culture of 12C47 was set up as negative control. The obtained colonies were isolated twice to assure phage-free bacterial cultures, and then tested against vB_Kpn_F48 by spot test to confirm their resistance to infection.

2.11. Extraction of Bacteriophage vB_Kpn_F48 DNA

Bacteriophage DNA was extracted from phage lysate with the kit Wizard® DNA Clean-Up System (Promega, Madison, WI, USA) according to the method described by Gill [33]. Prior to DNA extraction, DNase (10 µg/mL) and RNase (10 µg/mL) were added to the phage lysate and the sample was incubated at RT for 2 h. After incubation, 2 volumes of precipitating solution (10% PEG-800, 1 M NaCl) were added, the mixture was incubated on ice for 1 h, centrifuged at 10,000× g for 10 min at 4 °C and the pellet was re-suspended in 0.5 mL of SM buffer. The obtained pellet was transferred to a new microcentrifuge tube and centrifuged for 5–10 s to remove any suspended particles. The supernatant was then transferred to a new tube and used for phage DNA extraction by using the above-mentioned kit. At the end of the extraction process, DNA samples were dissolved in 0.1 mL of sterile ddH2O preheated to 80 °C and stored at 4 °C.

2.12. Genome Sequencing

The genome of vB_Kpn_F48 was sequenced with the MiSeq instrument (Illumina Inc., San Diego, CA, USA) and a paired-ends approach (2 × 250 bp) by using the kit Illumina Nextera XT™. Direct Sanger sequencing was performed to determine the 5′- and 3′-ends of the phage genome and to close gaps occurring between contigs using the primers reported in Table S1.

2.13. Bioinformatics Analysis of Phage Genome

Reads obtained from genome sequencing were assembled using the SPAdes software [34] into 149 nodes. Nodes having a coverage <10× were considered of chromosomal origin or artifacts and thus removed from the subsequent analysis. A total of 10 nodes were then analyzed by BLASTN software using the nr database (http://blast.ncbi.nlm.nih.gov/) to remove additional nodes of chromosomal origin. A total of 8/10 nodes were then retained and ordered by using the characterized phage Bp7 (Accession number: NC_019500), the closest homolog deposited in the International Nucleotide Standard Database Collaboration (INSDC) databases, as template. A PCR approach coupled with Sanger sequencing was employed to verify the order of the nodes and to close gaps. Finally, direct Sanger sequencing on whole phage DNA preparations was employed to verify the 5′- and 3′-ends of the phage genome. A single DNA molecule of 170,764 bp was thus obtained and annotated by using the Rapid Annotation using Subsystem Technologies (RAST) web-service [35]. The on-line instance of tRNAScan-SE [36] was used to identify phage tRNA genes, while host tRNA genes were predicted using ARAGORN [37]. Automatic annotation was manually reviewed by BLASTP analysis against RefSeq proteins deposited in the INSDC databases. Analysis of conserved protein domains was performed by using the CD-Search tool [38] and the results were filtered to remove non-specific hits. Phylogenetic analysis were performed by using the large subunit terminases or Gp23 protein sequences of bacteriophages of the Tevenvirinae subfamily reported by the International Committee on Taxonomy of Viruses (ICTV) classification (https://talk.ictvonline.org/taxonomy/; last accessed 19 April 2018). In both cases closest homologues, i.e., proteins having a ≥85% identity in a BLAST search (https://blast.ncbi.nlm.nih.gov/), have been also included. Protein alignments and trees, generated by using the Neighbor Joining method and 1000 bootstraps, were obtained using ClustalW [39]. Analysis of phage genomes were conducted using the Genome-BLAST Distance Phylogeny (GBDP) method implemented by the VICTOR webserver, with settings recommended for prokaryotic viruses [40]. Phage lifestyles were predicted using Phage Classification Tool Set (PHACTS) [41].

3. Results

3.1. Phage Isolation and Morphological Characterization

The strain 12C47, an ST101 KPC-producing Klebsiella pneumoniae (KPC-Kp) isolated in Italy in 2011, was used as host to investigate the presence of virulent phages in a wastewater sample of a large tertiary-care teaching hospital located in central Italy, where KPC-Kp have been endemic since 2009 [22,42]. Results from this experiment revealed the presence of ≈50 clear small plaques (diameter < 1 mm) all characterized by a similar morphology, suggesting the presence of a single lytic phage. One plaque was picked up, and used for the propagation of the selected phage, named vB_Kpn_F48. Results from TEM analysis showed that vB_Kpn_F48 was characterized by a prolated head, approximately 120 nm × 80 nm, which is connected by an apparent collar to a helical, contractile tail (≈100 nm long) that ends with a baseplate provided with tail pins and several tail fibers (Figure 1). These morphological features suggested that vB_Kpn_F48 belongs to the family Myoviridae, order Caudovirales.

3.2. Phage Host Range

A total of 103 clinical isolates (61 K. pneumoniae of different clonal lineages and 42 gram negatives not belonging to the K. pneumoniae species) plus 16 commensal E. coli from healthy children were used to evaluate the host range of vB_Kpn_F48 (Table 1). Results demonstrated that this phage had a lytic activity specific to K. pneumoniae strains of ST101 (n = 11) and single locus variants thereof (i.e., ST1633, n = 1; ST2502, n = 2). All the other tested strains, including K. pneumoniae (n = 47), belonging to different clonal lineages (i.e., CG258) [43,44], were found to be insensitive to the infection by vB_Kpn_F48.

3.3. EOP of Phage vB_Kpn_F48

The EOP analysis revealed a high productive infection of phage vB_Kpn_F48 for 9 of the 14 strains sensitive to vB_Kpn_F48 in the spot assay. A medium production has been observed for the isolate belonging to ST1633, while the remaining four strains resulted in inefficient production (Table 2). An inefficient production of the phage could be explained either by an abortive infection or a lysis from without phenomenon, two processes that involve the adsorption of a high number of phage particles onto the bacterial cell wall and end with the rapid disruption of the bacterial cell-forming clear zones on a bacterial plate without phage production [45].

3.4. Latency Period, Eclipse Period and Burst Size Determination

Results from one-step growth experiments showed a triphasic curve indicating that vB_Kpn_F48 was characterized by relatively short eclipse and latency periods (both less than 10 min) followed by a rise period of 40 min and a growth plateau reached in 40 min (Figure 2). The burst size of vB_Kpn_F48 was computed as 72 phages particles per infected bacteria. The increase in phage titer reported after one hour of infection represents the beginning of the second replication cycle, and thus data from this phase were not considered for the burst size computation.

3.5. Sensitivity to Physical Parameters

Data obtained from stability test vs. temperature variations demonstrated that the infectivity of vB_Kpn_F48 was overall stable in the range between 25 and 60 °C. Conversely, a high decrease of the infective capacity (~4 log) was observed after incubation at 65 °C for 60 min with a complete inactivation of vB_Kpn_F48 after incubation at 70 °C for 10 min (Figure 3). Results of stability test at different pH values indicated that vB_Kpn_F48 retained the maximum infectivity after incubation at pH values ranging from 4.0 to 8.0, while a reduction of approximately 40% was detected at pH 2.0 and pH 3.0. A decrease in phage infectivity was also detected at pH 9.0 (25%) and at pH 10.0 (45%). Anyway, a high phage viability was observed in all the tested conditions (Figure 4).

3.6. Killing Dynamic of vB_Kpn_F48 against the 12C47 Strain

To evaluate the killing effect of phage vB_Kpn_F48 against the 12C47 strain, liquid cultures of the bacterial host in the exponential phase were infected with the phage at three different MOI and cell number was monitored over time (Figure 5). Data obtained from this assay showed a sigmoid curve for all conditions characterized by a lag phase that is directly correlated with the MOI. In particular, lag phases of approximately 1, 2, or 2.5 h were observed by using MOIs of 0.01, 0.1 or 1, respectively. After 4 h the cultures, at all the tested MOIs, showed a 0.5–1 log reduction in cell count, even if the reduction of viable cells doesn’t correlate with MOIs, with MOI of 0.01 that resulted in the higher killing effect. A similar trend, i.e., the absence of an inverse correlation between MOI and bacterial growth, has been previously observed and correlated to the appearance of phage-resistant/persister bacteria following a random fluctuation model [47,48].

3.7. Frequency of Emergence of Phage-Resistant Mutants

The frequency of emergence of phage-resistant mutant bacterial cells was estimated to be 1.5 × 10−7 mutants per total cells count for bacteriophage vB_Kpn_F48. This frequency is similar to that obtained for other Myoviruses, e.g., phage Acibel004 infecting A. baumannii that showed a mutation frequency rate of 1.2 × 10−7 mutants per total cells count [32]. Resistant mutants were phenotypically undistinguishable from parental strain.

3.8. Genome Analysis

Molecular characterization, performed by high-throughput DNA sequencing and Sanger sequencing for the resolution of the 5′- and 3′-ends and gap closing, revealed that the genome of vB_Kpn_F48 is composed by a linear dsDNA molecule of 170,764 bp and a GC content of 40.8%. No repeated terminal sequences were detected at the 5′- and 3′-ends, consistent with other members of the Myoviridae family. A total of 283 putative coding regions (CDSs) have been detected by RAST analysis. Most of the predicted CDSs (n = 239, corresponding to 84.4%) are encoded on the same strand. The shortest CDS encoded a putative protein of 37 amino acid residues (CDS 140), while the longest encodes a putative protein of 1403 amino acid residues (CDS 156). The majority of predicted CDSs have an ATG initial codon (n = 261, corresponding to 92.2%), 17 start with GTG (6%), and the remaining five with TTG (1.8%). A specific putative function (transcriptional factors, structural proteins, enzymes involved in the replication and degradation of DNA) could be assigned to 120 of 283 deduced proteins (42.4%), with 21 of 120 (17.5%) showing high sequence identity to proteins described in phages of the Tevenvirinae subfamily. No specific function was assigned to the remaining 163 CDSs (57.6%; Table S2). No significant similarity with known antibiotic resistance determinants, virulence or toxin proteins, or with elements commonly associated with lysogeny (i.e., integrases, repressors and antirepressors) was revealed. A lytic lifestyle was predicted by PHACTS analysis, and this prediction was also supported by the presence of the ndd and denB genes whose deduced products shared a high degree of similarity (73% and 63% respectively) with the correspondent endonucleases encoded by the T4 phage. A lysozyme-like superfamily domain was detected in three deduced aminoacid sequences (AUO78644, AUO78846 and AUO78885) which were homologous to the T4 Gpe, Gp25 and Gp5 proteins (85%, 78% and 79% similarity, respectively). A total of 8 tRNA were detected by the tRNA-SCAN tool, and 7 were confirmed also by using ARAGORN. Genes encoding tRNAs are organized in a modular fashion, a feature common among the Caudovirales, and are equally distributed upstream and downstream the regions flanking ORF 274-ORF 278.
Comparative analysis of whole genome performed against phages deposited in the INSDC databases revealed that vB_Kpn_F48 is most closely related with the characterized E. coli Bp7 phage (overall nucleotide identity, 52.3%), a member of the Myoviridae family, Tevenvirinae subfamily [49,50] (Figure 6).
The nucleotide sequence of vB_Kpn_F48 was deposited in the GenBank database under accession number MG746602.

3.9. Phylogenetic Analysis

Results of BLASTP searches using the large terminase subunit revealed that vB_Kpn_F48 is a member of Tevenvirinae subfamily of Myoviridae. A phylogenetic tree of large terminase subunits gave results highly consistent with the current ICTV taxonomy, but suggested that vB_Kpn_F48 could not be assigned to any of the known genus (Figure 7). This observation was also confirmed by the analysis of Gp23 proteins. A phylogenetic analysis of the whole phage genome, performed by using the VICTOR web service, confirmed these findings, strongly suggesting that vB_Kpn_F48 is a member of a novel genus of the Tevenvirinae subfamily (Figure S1).

4. Discussion

The spread of antibiotic-resistant pathogens constitutes a serious matter in the clinical setting, given the scarcity of available treatment options. In particular, resistance to carbapenems and its association to MDR phenotypes in Enterobacteriaceae, including K. pneumoniae, is one of the major clinical challenges.
Among the most diffused HiRiCs of K. pneumoniae, those of CG101 are on the rise. Their propensity to acquire different clinically relevant resistance determinants, together with the ability to produce biofilm and several virulence factors are likely key factors for their success [51].
Bacteriophages could provide a valuable tool to control the dissemination of MDR microorganisms, especially HiRiCs. In addition, bacteriophages could be used for decolonization purposes, leading to the reduction of the load of specific bacterial clones and thus limiting the chance of their spreading. Due to their high specificity, phages can avoid also the alteration of the natural microbiological equilibrium occurring in the human microbiota when conventional antibiotics are used [52]. These features, together with their capacity to overcome bacterial antibiotic-resistance, make bacteriophages potential alternatives for clinical applications in infections caused by MDR bacteria [53,54].
In this work, we have described a novel lytic bacteriophage characterized by a narrow spectrum of lytic activity towards isolates of CG101. It is worth noting that K. pneumoniae isolates belonging to ST101 and variants thereof are spreading not only in Europe, including Italy, but also in other countries such as Algeria and Malaysia, where hospital outbreaks sustained by K. pneumoniae of ST101 have been reported [12,13]. To the best of our knowledge, this work represents the first report of a lytic phage that specifically targets strains of CG101. It is interesting to notice by the EOP test that both strains of ST2502 (CG101) gave an inefficient production of vB_Kpn_F48, maybe due to a reduced efficiency of phage recognition based on genetic mutations in this clonal lineage. Furthermore, all strains of CG101 used in this work were predicted from wzi sequencing to express a K17 serotype [26]. This may suggest that, differently from E. coli phage T4 that targets lipopolysaccharide or outer membrane OmpC as receptors [55], the cell structures recognized by vB_Kpn_F48 are components of the capsular polysaccharide. The lack of strains of the K17 serotype not belonging to CG101 in our collection didn’t allow to test such a correlation, but genomic analyses of phage resistant mutants are currently ongoing and will be the subject of future investigations aimed to characterize vB_Kpn_F48 receptors.
Morphological characterization performed by TEM showed that vB_Kpn_F48 is a member of the family Myoviridae, order Caudovirales. Results of phylogenetic analysis performed using markers previously employed in several phylogenetic studies of the T4- and T7-like phages [56,57,58,59], strongly suggested that vB_Kpn_F48 is a member of a novel genus of the Tevenvirinae subfamily. This finding is also supported by the phylogenetic analysis of the whole phage genome which shows a full consistency of the obtained trees and current ICTV taxonomy, with very high bootstrap values, and again confirmed that vB_Kpn_F48 forms a distinct clade of the Tevenvirinae subfamily. For these reasons, we propose that vB_Kpn_F48 represents a new genus within the Tevenvirinae, which we tentatively named “F48viruses”.
Physiological characterization showed that vB_Kpn_F48 is characterized by relatively short latent and eclipse periods and a low burst size of 72 phage particles released per infected bacteria. The result is a slight reduction in bacterial cells count over time as highlighted by the killing-curve, with a low frequency of occurrence of phage-resistant mutant, one of the major important infection parameters for the therapeutic use of bacteriophages. Results from stability test to physicochemical parameters demonstrated that vB_Kpn_F48 is exceedingly stable to temperature variations if compared to other lytic phages of the Myoviridae family targeting K. pneumoniae, e.g., the phage vB_KpnM_KP15 [60] which showed a 100-fold decrease in titer after 10 min at 60 °C. Similar results were obtained for stability to pH variations. These features, together with the host specificity, its close genetic relatedness to a well-known group of strictly lytic phages, together with the absence of the genes associated with lysogeny and the relatively low frequency of occurrence of phage-resistant mutants, make vB_Kpn_F48 an excellent candidate of interest for potential clinical applications [61], such as decontamination, decolonization and/or therapy. Finally, the presence in vB_Kpn_F48 of several T4-like putative endonucleases (e.g., Ndd and DenB homologues) suggests that this phage is able to prevent the “superspreader” effect [62], i.e., the release of intact, transformable plasmid DNA that upon lysis can be transferred horizontally by transformation, making vB_Kpn_F48 a promising candidate to hinder the colonization process.

Supplementary Materials

The following are available online at https://www.mdpi.com/1999-4915/10/9/482/s1, Table S1: Primers used for the vB_Kpn_F48 genome characterization, Table S2: General features of the coding regions of phage vB_Kpn_F48, Figure S1: Phylogenomic GBDP tree inferred using the formula D4 yielding the maximum average support of 71% among the three different formulas obtained by the VICTOR web server.

Author Contributions

M.M.D., G.M.R. and M.C.T. conceived the study idea; N.C., M.M.D., G.M.R. and M.C.T. designed the experiments; F.A. and M.M.D. isolated the bacteriophage; N.C., P.M., and E.D. characterized the phage physiology; P.L. performed TEM analysis; V.D.P. performed the DNA sequencing; N.C., M.M.D., P.M. and E.D. performed the bioinformatics analysis; M.M.D., G.M.R. and M.C.T. jointly supervised the work; N.C., M.F., M.M.D., G.M.R. and M.C.T. critically analysed the results and the discussion; N.C., M.M.D., G.M.R. and M.C.T. wrote the paper. E.D. and F.A conducted the research during a training period at the Department of Medical Biotechnologies, University of Siena, Siena, Italy. All authors revised and approved the manuscript.

Funding

This research received no external funding.

Acknowledgments

We would like to acknowledge Kostas Papagiannitsis, Lucia Pallecchi, and Alberto Antonelli for providing some bacterial isolates to carry out phage host experiments.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Rossolini, G.M.; Arena, F.; Pecile, P.; Pollini, S. Update on the antibiotic resistance crisis. Clin. Opin. Pharmacol. 2014, 18, 56–60. [Google Scholar] [CrossRef] [PubMed]
  2. Bush, K. Alarming β-lactamase-mediated resistance in multidrug-resistant Enterobacteriaceae. Curr. Opin. Microbiol. 2010, 13, 558–564. [Google Scholar] [CrossRef] [PubMed]
  3. Michael, C.A.; Dominey-Howes, D.; Labbate, M. The antimicrobial resistance crisis: Causes, consequences, and management. Front. Public Health 2014, 2, 145. [Google Scholar] [CrossRef] [PubMed]
  4. Prestinaci, F.; Pezzotti, P.; Pantosti, A. Antimicrobial resistance: A global multifaceted phenomenon. Pathog. Glob. Health. 2015, 109, 309–318. [Google Scholar] [CrossRef] [PubMed]
  5. Navon-Venezia, S.; Kondratyeva, K.; Carattoli, A. Klebsiella pneumoniae: A major worldwide source and shuttle for antibiotic resistance. FEMS Microbiol. Rev. 2017, 41, 252–275. [Google Scholar] [CrossRef] [PubMed]
  6. Mammina, C.; Bonura, C.; Aleo, A.; Fasciana, T.; Brunelli, T.; Pesavento, G.; Degl’Innocenti, R.; Nastasi, A. Sequence type 101 (ST101) as the predominant carbapenem-non-susceptible Klebsiella pneumoniae clone in an acute general hospital in Italy. Int. J. Antimicrob. Agents. 2012, 39, 543–545. [Google Scholar] [CrossRef] [PubMed]
  7. Bonura, C.; Giuffrè, M.; Aleo, A.; Fasciana, T.; Di Bernardo, F.; Stampone, T.; Giammanco, A.; MDR-GN Working Group; Palma, D.M.; Mammina, C. An update of the evolving epidemic of blaKPC carrying Klebsiella pneumoniae in Sicily, Italy, 2014: Emergence of multiple non-ST258 clones. PLoS ONE 2015, 10, e0132936. [Google Scholar] [CrossRef] [PubMed]
  8. Conte, V.; Monaco, M.; Giani, T.; D’Ancona, F.; Moro, M.L.; Arena, F.; D’Andrea, M.M.; Rossolini, G.M.; Pantosti, A.; AR-ISS Study Group on Carbapenemase-Producing K. pneumoniae. Molecular epidemiology of KPC-producing Klebsiella pneumoniae from invasive infections in Italy: Increasing diversity with predominance of the ST512 clade II sublineage. J. Antimicrob. Chemother. 2016, 71, 3386–3391. [Google Scholar] [CrossRef] [PubMed]
  9. Mshana, S.E.; Fritzenwanker, M.; Falgenhauer, L.; Domann, E.; Hain, T.; Chakraborty, T.; Imirzalioglu, C. Molecular epidemiology and characterization of an outbreak causing Klebsiella pneumoniae clone carrying chromosomally located blaCTX-M-15 at a German University-Hospital. BMC Microbiol. 2015, 15, 122. [Google Scholar] [CrossRef] [PubMed]
  10. Skalova, A.; Chudejova, K.; Rotova, V.; Medvecky, M.; Studentova, V.; Chudackova, E.; Lavicka, P.; Bergerova, T.; Jakubu, V.; Zemlickova, H.; et al. Molecular Characterization of OXA-48-Like-Producing Enterobacteriaceae in the Czech Republic and Evidence for Horizontal Transfer of pOXA-48-Like Plasmids. Antimicrob. Agents Chemother. 2017, 61. [Google Scholar]
  11. Oteo, J.; Pérez-Vázquez, M.; Bautista, V.; Ortega, A.; Zamarrón, P.; Saez, D.; Fernández-Romero, S.; Lara, N.; Ramiro, R.; Aracil, B.; et al. The spread of KPC-producing Enterobacteriaceae in Spain: WGS analysis of the emerging high-risk clones of Klebsiella pneumoniae ST11/KPC-2, ST101/KPC-2 and ST512/KPC-3. J. Antimicrob. Chemother. 2016, 71, 3392–3399. [Google Scholar] [CrossRef] [PubMed]
  12. Loucif, L.; Kassah-Laouar, A.; Saidi, M.; Messala, A.; Chelaghma, W.; Rolain, J.M. Outbreak of OXA-48-producing Klebsiella pneumoniae involving a Sequence Type 101 clone in Batna University Hospital, Algeria. Antimicrob. Agents Chemother. 2016, 60, 7494–7497. [Google Scholar] [PubMed]
  13. Low, Y.M.; Yap, P.S.; Abdul Jabar, K.; Ponnampalavanar, S.; Karunakaran, R.; Velayuthan, R.; Chong, C.W.; Abu Bakar, S.; Md Yusof, M.Y.; Teh, C.S. The emergence of carbapenem resistant Klebsiella pneumoniae in Malaysia: Correlation between microbiological trends with host characteristics and clinical factors. Antimicrob. Resist. Infect. Control 2017, 6, 5. [Google Scholar] [CrossRef] [PubMed]
  14. De Laveleye, M.; Huang, T.D.; Bogaerts, P.; Berhin, C.; Bauraing, C.; Sacré, P.; Noel, A.; Glupczynski, Y.; multicenter study group. Increasing incidence of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in Belgian hospitals. Eur. J. Clin. Microbiol. Infect. Dis. 2017, 36, 139–146. [Google Scholar] [CrossRef] [PubMed]
  15. Del Franco, M.; Paone, L.; Novati, R.; Giacomazzi, C.G.; Bagattini, M.; Galotto, C.; Montanera, P.G.; Triassi, M.; Zarrilli, R. Molecular epidemiology of carbapenem resistant Enterobacteriaceae in Valle d’Aosta region, Italy, shows the emergence of KPC-2 producing Klebsiella pneumoniae clonal complex 101 (ST101 and ST1789). BMC Microbiol. 2015, 15, 263–269. [Google Scholar] [CrossRef] [PubMed]
  16. Poulou, A.; Voulgari, E.; Vrioni, G.; Koumaki, V.; Xidopoulos, G.; Chatzipantazi, V.; Markou, F.; Tsakris, A. Outbreak caused by an ertapenem-resistant, CTX-M-15-producing Klebsiella pneumoniae sequence type 101 clone carrying an OmpK36 porin variant. J. Clin. Microbiol. 2013, 51, 3176–3182. [Google Scholar] [CrossRef] [PubMed]
  17. Potron, A.; Poirel, L.; Rondinaud, E.; Nordmann, P. Intercontinental spread of OXA-48 β-lactamase-producing Enterobacteriaceae over a 11-year period, 2001 to 2011. Eurosurveillance 2013, 18, 20549. [Google Scholar] [CrossRef] [PubMed]
  18. Jayol, A.; Poirel, L.; Dortet, L.; Nordmann, P. National survey of colistin resistance among carbapenemase-producing Enterobacteriaceae and outbreak caused by colistin-resistant OXA-48-producing Klebsiella pneumoniae, France, 2014. Eurosurveillance 2016, 21, 30339. [Google Scholar] [CrossRef] [PubMed]
  19. Pitart, C.; Solé, M.; Roca, I.; Fàbrega, A.; Vila, J.; Marco, F. First outbreak of a plasmid-mediated carbapenem-hydrolyzing OXA-48 beta-lactamase in Klebsiella pneumoniae in Spain. Antimicrob. Agents Chemother. 2011, 55, 4398–4401. [Google Scholar] [CrossRef] [PubMed]
  20. Pires, D.P.; Cleto, S.; Sillankorva, S.; Azeredo, J.; Lu, T.K. Genetically engineered phages: A review of advances over the last decade. Microbiol. Mol. Biol. Rev. 2016, 80, 523–543. [Google Scholar] [CrossRef] [PubMed]
  21. Domingo-Calap, P.; Georgel, P.; Bahram, S. Back to the future: Bacteriophages as promising therapeutic tools. HLA 2016, 87, 133–140. [Google Scholar] [CrossRef] [PubMed]
  22. Giani, T.; Pini, B.; Arena, F.; Conte, V.; Bracco, S.; Migliavacca, R.; AMCLI-CRE Survey Participants; Pantosti, A.; Pagani, L.; Luzzaro, F.; Rossolini, G.M. Epidemic diffusion of KPC carbapenemase-producing Klebsiella pneumoniae in Italy: Results of the first countrywide survey, 15 May to 30 June 2011. Eurosurveillance 2013, 18, 20489. [Google Scholar] [PubMed]
  23. Adams, M. Bacteriophage; Interscience Publishers: New York, NY, USA, 1959; pp. 137–159. [Google Scholar]
  24. Di Lallo, G.; Evangelisti, M.; Mancuso, F.; Ferrante, P.; Marcelletti, S.; Tinari, A.; Superti, F.; Migliore, L.; D’Addabbo, P.; Frezza, D.; et al. Isolation and partial characterization of bacteriophages infecting Pseudomonas syringae pv. actinidiae, causal agent of kiwifruit bacterial canker. J. Basic Microbiol. 2014, 54, 1210–1221. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  25. Hsu, C.R.; Lin, T.L.; Pan, Y.J.; Hsieh, P.F.; Wang, J.T. Isolation of a bacteriophage specific for a new capsular type of Klebsiella pneumoniae and characterization of its polysaccharide depolymerase. PLoS ONE 2013, 8, e70092. [Google Scholar] [CrossRef] [PubMed]
  26. Brisse, S.; Passet, V.; Haugaard, A.B.; Babosan, A.; Kassis-Chikhani, N.; Struve, C.; Decré, D. wzi Gene sequencing, a rapid method for determination of capsular type for Klebsiella strains. J. Clin. Microbiol. 2013, 51, 4073–4078. [Google Scholar] [CrossRef] [PubMed]
  27. Khan Mirzaei, M.; Nilsson, A.S. Isolation of phages for phage therapy: A comparison of spot tests and ffficiency of plating analyses for determination of host range and efficacy. PLoS ONE 2015, 10, e0118557. [Google Scholar] [CrossRef] [PubMed]
  28. D’Andrea, M.M.; Marmo, P.; Henrici De Angelis, L.; Palmieri, M.; Ciacci, N.; Di Lallo, G.; Demattè, E.; Vannuccini, E.; Lupetti, P.; Rossolini, G.M.; et al. φBO1E, a newly discovered lytic bacteriophage targeting carbapenemase-producing Klebsiella pneumoniae of the pandemic Clonal Group 258 clade II lineage. Sci. Rep. 2017, 7, 2614. [Google Scholar] [CrossRef] [PubMed]
  29. Adams, M.H. Bacteriophage; Interscience Publishers: New York, NY, USA, 1959; pp. 450–456. [Google Scholar]
  30. Clinical and Laboratory Standards Institute. Methods for Determining Bactericidal Activity of Antimicrobial Agents: Approved Guidelines; M26-A; Clinical and Laboratory Standards Institute: Wayne, PA, USA, 1999. [Google Scholar]
  31. Murray, P.; Baron, E.; Jorgensen, J.; Pfaller, M.; Yolken, R. Manual of Clinical Microbiology, 8th ed.; American Society for Microbiology: Washington, DC, USA, 2003. [Google Scholar]
  32. Merabishvili, M.; Vandenheuvel, D.; Kropinski, A.M.; Mast, J.; de Vos, D.; Verbeken, G.; Noben, J.P.; Lavigne, R.; Vaneechoutte, M.; Pirnay, J.P. Characterization of Newly Isolated Lytic Bacteriophages Active against Acinetobacter baumannii. PLoS ONE 2014, 9, e104853. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  33. Gill, J.J. Phage Genomic DNA Extraction. OpenWetWare, 2015. Available online: https://openwetware.org/wiki/Gill:Phage_genomic_DNA_extraction (accessed on 31 May 2017).
  34. Bankevich, A.; Nurk, S.; Antipov, D.; Gurevich, A.A.; Dvorkin, M.; Kulikov, A.S.; Lesin, V.M.; Nikolenko, S.I.; Pham, S.; Prjibelski, A.D.; et al. SPAdes: A new genome assembly algorithm and its applications to single-cell sequencing. J. Comput. Biol. 2012, 19, 455–477. [Google Scholar] [CrossRef] [PubMed]
  35. Aziz, R.K.; Bartels, D.; Best, A.A.; DeJongh, M.; Disz, T.; Edwards, R.A.; Formsma, K.; Gerdes, S.; Glass, E.M.; Kubal, M.; et al. The RAST Server: Rapid annotations using subsystems technology. BMC Genom. 2008, 9, 75. [Google Scholar] [CrossRef] [PubMed]
  36. Lowe, T.M.; Chan, P.P. tRNAscan-SE On-line: Integrating search and context for analysis of transfer RNA genes. Nucleic Acids Res. 2016, 44, W54–W57. [Google Scholar] [CrossRef] [PubMed]
  37. Laslett, D.; Canback, B. ARAGORN, a program to detect tRNA genes and tmRNA genes in nucleotide sequences. Nucleic Acids Res. 2004, 32, 11–16. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  38. Marchler-Bauer, A.; Derbyshire, M.K.; Gonzales, N.R.; Lu, S.; Chitsaz, F.; Geer, L.Y.; Geer, R.C.; He, J.; Gwadz, M.; Hurwitz, D.I.; et al. CDD: NCBI’s conserved domain database. Nucleic Acids Res. 2015, 43, D222–D226. [Google Scholar] [CrossRef] [PubMed]
  39. Larkin, M.A.; Blackshields, G.; Brown, N.P.; Chenna, R.; McGettigan, P.A.; McWilliam, H.; Valentin, F.; Wallace, I.M.; Wilm, A.; Lopez, R.; et al. Clustal W and Clustal X version 2.0. Bioinformatics 2007, 23, 2947–2948. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  40. Meier-Kolthoff, J.P.; Göker, M. VICTOR: Genome-based phylogeny and classification of prokaryotic viruses. Bioinformatics 2017, 33, 3396–3404. [Google Scholar] [CrossRef] [PubMed]
  41. McNair, K.; Bailey, B.A.; Edwards, R.A. PHACTS, a computational approach to classifying the lifestyle of phages. Bioinformatics 2012, 28, 614–618. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  42. Giani, T.; Arena, F.; Vaggelli, G.; Conte, V.; Chiarelli, A.; Henrici De Angelis, L.; Fornaini, R.; Grazzini, M.; Niccolini, F.; Pecile, P.; et al. Large Nosocomial Outbreak of Colistin-Resistant, Carbapenemase-Producing Klebsiella pneumoniae Traced to Clonal Expansion of an mgrB Deletion Mutant. J. Clin. Microbiol. 2015, 53, 3341–3344. [Google Scholar] [CrossRef] [PubMed]
  43. Chen, L.; Mathema, B.; Pitout, J.D.D.; DeLeo, F.R.; Kreiswirth, B.N. Epidemic Klebsiella pneumoniae ST258 Is a Hybrid Strain. Mbio 2014, 5, e01355-14. [Google Scholar] [CrossRef] [PubMed]
  44. D’Andrea, M.M.; Amisano, F.; Giani, T.; Conte, V.; Ciacci, N.; Ambretti, S.; Santoriello, L.; Rossolini, G.M. Diversity of capsular polysaccharide gene clusters in KPC-producing Klebsiella pneumoniae clinical isolates of Sequence Type 258 involved in the Italian epidemic. PLoS ONE 2014, 9, e96827. [Google Scholar]
  45. Hyman, P.; Abedon, S.T. Bacteriophage host range and bacterial resistance. Adv. Appl. Microbiol. 2010, 70, 217–248. [Google Scholar] [PubMed]
  46. Viazis, S.; Akhtar, M.; Feirtag, J.; Brabban, A.D.; Diez-Gonzalez, F. Isolation and characterization of lytic bacteriophages against enterohaemorrhagic Escherichia coli. Appl. Microbiol. 2011, 110, 1323–1331. [Google Scholar] [CrossRef] [PubMed]
  47. Henry, M.; Biswas, B.; Vincent, L.; Mokashi, V.; Schuch, R.; Bishop-Lilly, K.A.; Sozhamannan, S. Development of a high throughput assay for indirectly measuring phage growth using the OmniLog™ system. Bacteriophage 2012, 2, 159–167. [Google Scholar] [CrossRef] [PubMed]
  48. Luria, S.E.; Delbrück, M. Mutations of bacteria from virus sensitivity to virus resistance. Genetics 1943, 28, 491–511. [Google Scholar] [PubMed]
  49. Zhang, C.; Liu, W.; Ren, H. Complete Genome Sequence of Bp7, an Escherichia coli Bacteriophage with a Wide Host Range. J. Virol. 2012, 86, 13832. [Google Scholar] [CrossRef] [PubMed]
  50. Zhang, C.; Li, W.; Liu, W.; Zou, L.; Yan, C.; Lu, K.; Ren, H. T4-Like Phage Bp7, a Potential Antimicrobial Agent for Controlling Drug-Resistant Escherichia coli in Chickens. Appl. Environ. Microbiol. 2013, 79, 5559–5565. [Google Scholar] [CrossRef] [PubMed]
  51. Melegh, S.; Schneider, G.; Horváth, M.; Jakab, F.; Emődy, L.; Tigyi, Z. Identification and characterization of CTX-M-15 producing Klebsiella pneumoniae clone ST101 in a Hungarian university teaching hospital. Acta Microbiol. Immunol. Hung. 2015, 62, 233–245. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  52. Yao, J.D.C.; Moellering, R.C., Jr. Antimicrobial agents. In Manual of Clinical Microbiology, 7th ed.; Murray, P.R., Baron, E.J., Pfaller, M.A., Tenover, F.C., Yolken, R.H., Eds.; American Society for Microbiology: Washington, DC, USA, 1995; pp. 1474–1504. [Google Scholar]
  53. Pirnay, J.P.; Blasdel, B.G.; Bretaudeau, L.; Buckling, A.; Chanishvili, N.; Clark, J.R.; Corte-Real, S.; Debarbieux, L.; Dublanchet, A.; De Vos, D.; et al. Quality and Safety Requirements for Sustainable Phage Therapy Products. Pharm. Res. 2015, 32, 2173–2179. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  54. Pirnay, J.P.; De Vos, D.; Verbeken, G.; Merabishvili, M.; Chanishvili, N.; Vaneechoutte, M.; Zizi, M.; Laire, G.; Lavigne, R.; Huys, I.; et al. The phage therapy paradigm: Prêt-à-porter or sur-mesure? Pharm. Res. 2011, 28, 934–937. [Google Scholar] [CrossRef] [PubMed]
  55. Montag, D.; Hashemolhosseini, S.; Henning, U. Receptor-recognizing proteins of T-even type bacteriophages. The receptor-recognizing area of proteins 37 of phages T4 TuIa and TuIb. J. Mol. Biol. 1990, 216, 327–334. [Google Scholar] [CrossRef]
  56. Chen, Z.; Schneider, T.D. Information theory based T7-like promoter models: Classification of bacteriophages and differential evolution of promoters and their polymerases. Nucleic Acids Res. 2005, 33, 6172–6187. [Google Scholar] [CrossRef] [PubMed]
  57. Adriaenssens, E.M.; Ceyssens, P.J.; Dunon, V.; Ackermann, H.W.; Van Vaerenbergh, J.; Maes, M.; de Proft, M.; Lavigne, R. Bacteriophages LIMElight and LIMEzero of Pantoea agglomerans, Belonging to the “phiKMV-Like Viruses”. Appl. Environ. Microbiol. 2011, 77, 3443–3450. [Google Scholar] [CrossRef] [PubMed]
  58. Ackermann, H.W.; Krisch, H.M.; Comeau, A.M. Morphology and genome sequence of phage ϕ1402: A dwarf myovirus of the predatory bacterium Bdellovibrio bacteriovorus. Bacteriophage 2011, 1, 138–142. [Google Scholar] [CrossRef] [PubMed]
  59. Cheepudom, J.; Lee, C.C.; Cai, B.; Meng, M. Isolation, characterization, and complete genome analysis of P1312, a thermostable bacteriophage that infects Thermobifida fusca. Front. Microbiol. 2015, 6, 959. [Google Scholar] [CrossRef] [PubMed]
  60. Kęsik-Szeloch, A.; Drulis-Kawa, Z.; Weber-Dąbrowska, B.; Kassner, J.; Majkowska-Skrobek, G.; Augustyniak, D.; Lusiak-Szelachowska, M.; Zaczek, M.; Górski, A.; Kropinski, A.M. Characterising the Biology of Novel Lytic Bacteriophages Infecting Multidrug Resistant Klebsiella pneumoniae. Virol. J. 2013, 10, 100. [Google Scholar] [CrossRef] [PubMed]
  61. Philipson, C.W.; Voegtly, L.J.; Lueder, M.R.; Long, K.A.; Rice, G.K.; Frey, K.G.; Biswas, B.; Cer, R.Z.; Hamilton, T.; Bishop-Lilly, K.A. Characterizing Phage Genomes for Therapeutic Applications. Viruses 2018, 10, 188. [Google Scholar] [CrossRef] [PubMed]
  62. Keen, E.C.; Bliskovsky, V.V.; Malagon, F.; Baker, J.D.; Prince, J.S.; Klaus, J.S.; Adhya, S.L. Novel “superspreader” bacteriophages promote horizontal gene transfer by transformation. MBio 2017, 8. [Google Scholar] [CrossRef] [PubMed]
Viruses 10 00482 g001 550
Figure 1. (A,B) Electron micrograph of phage vB_Kpn_F48 negatively stained with uranyl acetate. Bars indicate 30 nm.
Figure 1. (A,B) Electron micrograph of phage vB_Kpn_F48 negatively stained with uranyl acetate. Bars indicate 30 nm.
Viruses 10 00482 g001
Viruses 10 00482 g002 550
Figure 2. One-step growth curve of bacteriophage vB_Kpn_F48. The PFU per infected cell at different time points in chloroform-treated cultures (blue) and in untreated cultures (orange) are shown. EP: eclipse period; BS: burst size. Each data point is the mean from three experiments. Standard deviations are shown as vertical lines.
Figure 2. One-step growth curve of bacteriophage vB_Kpn_F48. The PFU per infected cell at different time points in chloroform-treated cultures (blue) and in untreated cultures (orange) are shown. EP: eclipse period; BS: burst size. Each data point is the mean from three experiments. Standard deviations are shown as vertical lines.
Viruses 10 00482 g002
Viruses 10 00482 g003 550
Figure 3. Thermal stability of vB_Kpn_F48. Each data point is the mean from three experiments. Standard deviations are shown as vertical lines.
Figure 3. Thermal stability of vB_Kpn_F48. Each data point is the mean from three experiments. Standard deviations are shown as vertical lines.
Viruses 10 00482 g003
Viruses 10 00482 g004 550
Figure 4. pH stability test of vB_Kpn_F48. Each data point is the mean from three experiments. Standard deviations are shown as vertical lines.
Figure 4. pH stability test of vB_Kpn_F48. Each data point is the mean from three experiments. Standard deviations are shown as vertical lines.
Viruses 10 00482 g004
Viruses 10 00482 g005 550
Figure 5. Time-kill assays with bacterial host in exponential phase. Viable cell count (log CFU/mL) of 12C47 cultures infected with vB_Kpn_F48 at MOI of 1 (blue), MOI of 0.1 (black), MOI of 0.01 (green) and the uninfected control (red) are shown. Each data point is the mean from three experiments. Standard deviations are shown as vertical lines.
Figure 5. Time-kill assays with bacterial host in exponential phase. Viable cell count (log CFU/mL) of 12C47 cultures infected with vB_Kpn_F48 at MOI of 1 (blue), MOI of 0.1 (black), MOI of 0.01 (green) and the uninfected control (red) are shown. Each data point is the mean from three experiments. Standard deviations are shown as vertical lines.
Viruses 10 00482 g005
Viruses 10 00482 g006 550
Figure 6. Comparative analysis between vB_Kpn_F48 and the Bp7 phage. Genetic map was constructed using EasyFig. ORFs are represented by orange arrows. Genome fragments having an identity ≥64% are connected by blue areas.
Figure 6. Comparative analysis between vB_Kpn_F48 and the Bp7 phage. Genetic map was constructed using EasyFig. ORFs are represented by orange arrows. Genome fragments having an identity ≥64% are connected by blue areas.
Viruses 10 00482 g006
Viruses 10 00482 g007 550
Figure 7. Phylogenetic tree of large subunit terminase of vB_Kpn_F48 (red) and homologues proteins of other members of the Tevenvirinae subfamily. Distinct genera are highlighted by circular sectors. Phages not assigned to specific genera by the ICTV classification (accessed 19 April 2018) are underlined. Bootstrap values ≥ 85% are indicated.
Figure 7. Phylogenetic tree of large subunit terminase of vB_Kpn_F48 (red) and homologues proteins of other members of the Tevenvirinae subfamily. Distinct genera are highlighted by circular sectors. Phages not assigned to specific genera by the ICTV classification (accessed 19 April 2018) are underlined. Bootstrap values ≥ 85% are indicated.
Viruses 10 00482 g007
Table
Table 1. Host spectrum of vB_Kpn_F48 towards K. pneumoniae clinical isolates. For each combination of sequence type/capsular genotype, the number of tested strains, the deduced capsular type basing on the wzi sequencing method and the result of the lysis test are reported (- = all strains were not lysed; + = all strains were lysed; ND = Not deducible).
Table 1. Host spectrum of vB_Kpn_F48 towards K. pneumoniae clinical isolates. For each combination of sequence type/capsular genotype, the number of tested strains, the deduced capsular type basing on the wzi sequencing method and the result of the lysis test are reported (- = all strains were not lysed; + = all strains were lysed; ND = Not deducible).
No. of Strains aSequence TypeCapsular Genotype bDeduced K-TypeLysis
11ST101wzi137K17+
2ST2502wzi137K17+
1ST11wzi75ND-
3ST14wzi2K2-
2ST15wzi24K24-
1ST1633wzi137K17+
1ST208wzi35K35-
3ST258wzi154ND-
1ST258wzi29K41-
1ST1879wzi154ND-
6ST307wzi173ND-
1ST340wzi50K15/K17/K50/K51/K52-
4ST37wzi96K38-
1ST42wzi41ND-
1ST45wzi101ND-
2ST512wzi154ND-
1ST540wzi33ND-
1ST554wzi154ND-
2ST641wzi38K38-
1ST745wzi154ND-
1ST23wzi1K1-
1ST11wzi174ND-
1ST489wzi171ND-
1ST3wzi3K3-
2ST16wzi50K15/K17/K50/K51/K52-
2ST730wzi356ND-
1ST147wzi64K14/K64-
1ST475wzi201-likeND-
1ST25wzi72K2-
1ST54wzi14K14-
1ST859wzi2K2-
1ST66wzi4K2-
1ST340wzi19K19-
a tested strains were from different hospitals, samples, patients and countries (Italy and Czech Republic) and were mostly epidemiological unrelated. b capsular genotyping was performed using the wzi method described by Brissè and colleagues [26].
Table
Table 2. Efficiency of plating (EOP) for phage vB_Kpn_F48 on K. pneumoniae isolates sensitive to the phage infection. For each isolate, the strain identifier, the sequence type and the EOP are reported. Each EOP value is the mean of three observations ± SD. EOP of the original strain of isolation is marked in bold and the type of phage production is ranked according to Viazis and colleagues [46].
Table 2. Efficiency of plating (EOP) for phage vB_Kpn_F48 on K. pneumoniae isolates sensitive to the phage infection. For each isolate, the strain identifier, the sequence type and the EOP are reported. Each EOP value is the mean of three observations ± SD. EOP of the original strain of isolation is marked in bold and the type of phage production is ranked according to Viazis and colleagues [46].
IDSequence TypeEOPProduction
12C47ST1011High
12C73ST1010.9 ± 0.2High
KPC174ST16330.44 ± 0.06Medium
5559ST1010.5 ± 0.2High
5583ST25020 aInefficient
C002ST1011.9 ± 0.7High
K13ST1012.62 ± 0.01High
K18ST101<0.001 bInefficient
6071ST25020Inefficient
12C29ST1012.2 ± 0.7High
5546ST1013.9 ± 0.3High
12C72ST1013.1 ± 0.3High
KPC220ST1010Inefficient
494647ST1010.9 ± 0.2High
a EOP = 0 indicates susceptibility to phage infection observed in the spot test but not in the EOP assay. b EOP < 0.001 indicates that the PFU produced by the phage on the target bacterium was more than 1000 times less than those observed on the indicator strain.

Share and Cite

MDPI and ACS Style

Ciacci, N.; D’Andrea, M.M.; Marmo, P.; Demattè, E.; Amisano, F.; Pilato, V.D.; Fraziano, M.; Lupetti, P.; Rossolini, G.M.; Thaller, M.C. Characterization of vB_Kpn_F48, a Newly Discovered Lytic Bacteriophage for Klebsiella pneumoniae of Sequence Type 101. Viruses 2018, 10, 482. https://doi.org/10.3390/v10090482

AMA Style

Ciacci N, D’Andrea MM, Marmo P, Demattè E, Amisano F, Pilato VD, Fraziano M, Lupetti P, Rossolini GM, Thaller MC. Characterization of vB_Kpn_F48, a Newly Discovered Lytic Bacteriophage for Klebsiella pneumoniae of Sequence Type 101. Viruses. 2018; 10(9):482. https://doi.org/10.3390/v10090482

Chicago/Turabian Style

Ciacci, Nagaia, Marco Maria D’Andrea, Pasquale Marmo, Elisa Demattè, Francesco Amisano, Vincenzo Di Pilato, Maurizio Fraziano, Pietro Lupetti, Gian Maria Rossolini, and Maria Cristina Thaller. 2018. "Characterization of vB_Kpn_F48, a Newly Discovered Lytic Bacteriophage for Klebsiella pneumoniae of Sequence Type 101" Viruses 10, no. 9: 482. https://doi.org/10.3390/v10090482

APA Style

Ciacci, N., D’Andrea, M. M., Marmo, P., Demattè, E., Amisano, F., Pilato, V. D., Fraziano, M., Lupetti, P., Rossolini, G. M., & Thaller, M. C. (2018). Characterization of vB_Kpn_F48, a Newly Discovered Lytic Bacteriophage for Klebsiella pneumoniae of Sequence Type 101. Viruses, 10(9), 482. https://doi.org/10.3390/v10090482

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop